Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness

NCT: NCT05694247 · TERMINATED

NCT IDNCT05694247
StatusTERMINATED
Start Date2024-06-27
Completion2026-05-04

Brief Summary

A Single Arm, Pivotal, Open Label, Multicenter Clinical Investigation to Evaluate the Clinical Safety and Performance of the CorNeat Keratoprosthesis, for Treatment of Corneal Blindness

Frequently Asked Questions

What is Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness?

Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness is a clinical trial registered under NCT05694247. Current status: TERMINATED.

What is the status of NCT05694247?

The current status of NCT05694247 (Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness) is: TERMINATED.

When did Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness start?

Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness started on 2024-06-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑